Table 3:
The receipt of adjuvant treatment by race/ethnicity for elderly women diagnosed with high-grade endometrial cancer
| Non-Hispanic White | Non-Hispanic Black | Hispanic | p-value* | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Treatment Variable | N | % | N | % | N | % | NHW:NHB | NHW:H | NHB:H |
|
| |||||||||
| Adjuvant therapy (a) | <0.001 | 0.080 | 0.642 | ||||||
|
| |||||||||
| Chemotherapy and radiation | 1,311 | 13% | 219 | 15% | 87 | 13% | |||
|
| |||||||||
| Chemotherapy only | 2,594 | 26% | 459 | 31% | 200 | 30% | |||
|
| |||||||||
| Radiation therapy only | 2,028 | 21% | 267 | 18% | 117 | 18% | |||
|
| |||||||||
| Neither | 3,958 | 40% | 529 | 36% | 252 | 38% | |||
|
| |||||||||
| FIGO Stage I | |||||||||
|
| |||||||||
| Adjuvant therapy received | 3,258 | 54% | 454 | 60% | 204 | 55% | 0.001 | 0.481 | 0.154 |
|
| |||||||||
| FIGO Stage II | |||||||||
|
| |||||||||
| Adjuvant therapy received | 715 | 70% | 153 | 72% | 59 | 77% | 0.534 | 0.221 | 0.449 |
|
| |||||||||
| FIGO Stage III | |||||||||
|
| |||||||||
| Adjuvant therapy received | 1,465 | 72% | 250 | 69% | 116 | 69% | 0.206 | 0.430 | 0.926 |
|
| |||||||||
| FIGO Stage IV | |||||||||
|
| |||||||||
| Adjuvant therapy received | 440 | 68% | 77 | 65% | 22 | 54% | 0.512 | 0.052 | 0.187 |
|
| |||||||||
| Adjuvant therapy delay (b) | 0.538 | 0.010 | 0.078 | ||||||
|
| |||||||||
| Adjuvant received within 12 wks | 5,435 | 92% | 860 | 91% | 355 | 88% | |||
|
| |||||||||
| Adjuvant delay (>12 wks) | 498 | 8% | 85 | 9% | 49 | 12% | |||
(a)
first course treatment defined as adjuvant treatment initiated within 6 months of surgery
(b)
among women who received adjuvant therapy
*
Pair-wise comparisons were made using chi-square tests
NHW: Non-Hispanic White; NHB: Non-Hispanic Black